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ABSTRACT 
 
Background: 
Numerous techniques have been described for nasal septal perforation repair, with 
various degrees of success in achieving closure.  Evidence supports the use of bilateral 
mucoperichondrial advancement flaps with interpositional grafting for greatest success.  
Many surgeons use autografts such as fascia, cartilage, bone, and pericranium, however, 
extracellular matrices have also become popular.   
 
Objective: 
We analyze factors determining the success of nasal septal perforations repaired using 
using an acellular, freeze-dried interpositional xenograft derived from Porcine Small 
Intestinal Submucosa (PSIS). 
 
Methods: 
Patients with septal perforation repaired by the senior author from 1998 to 2006 were 
examined in a retrospective chart review with regard to perforation size, etiology, pre- 
and postoperative symptoms, follow-up, outcomes and complications. 
 
Results: 
Forty-seven PSIS repairs were performed on 46 patients. Two procedures were planned 
staged procedures.  Of the total 47 procedures, 41 (87.2%) continued to be closed at the 
site of repair during the follow up period. Follow up ranged from 6 months to 4.9 years 
with a mean of 18.3 months.  Two patients (4.3%) were found to have perforations at the 
site of closure in the immediate post-operative period. One patient (2.1%) perforated at 
the site of closure after the immediate post-operative period. Subjective symptom scores 
demonstrated improvement in crusting, epistaxis and obstruction postoperatively.  Larger 
perforations correlated with poorer outcomes.     
 
Conclusions: 
The authors conclude that closure of nasal septal perforation with an interpositional 
xenograft derived from PSIS compares favorably to published results for autografts with 
advantages including absence of donor site morbidity, easy graft modification and 
manipulation, and shorter operative time. 
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Introduction: 
Numerous techniques have been advocated for repair of nasal septal perforations 
[1-3]. For symptomatic patients who fail conservative management, the surgical goals 
can largely be agreed upon to include:  1) Restoration of normal function and physiology 
to the nose and 2) Reduction of symptoms [4].  However, a consensus on the ideal 
procedure to achieve complete closure of nasal septal perforations remains elusive.   
Reconstruction of the nasal septum in three distinct layers using bilateral 
mucoperichondrial flaps with interpositional grafting has gained widespread acceptance 
[1, 2, 4, 5].  This method consistently demonstrates closure rates greater than 70% and 
frequently higher than 90% in numerous series. These rates match favorably with respect 
to closure by mucoperichondrial advancement omitting the use of interposition grafting 
[1]. The mechanism for this greater success is theorized to include 1) improved mucosal 
cellular migration with the graft acting as a scaffold 2) the graft providing a barrier 
between the bilateral incision lines during healing and 3) the allowance of incomplete 
mucosal closure on one side of the septum where excessive tension would be required [1, 
4].  Even amongst surgeons who employ this method to achieve closure of nasal septal 
perforations, there is considerable diversity in the choice of interpositional graft material.   
 Autologous grafts used for the repair of nasal septal perforations include 
temporalis fascia, septal cartilage and bone, pericranium, mastoid bone and 
perichondrium, tragal cartilage and perichondrium, ethmoid bone, iliac crest, conchal 
cartilage, and skin graft [2, 6].  Recently, use of manufactured allografts such as freeze-
dried acellular human dermis, xenografts such porcine small intestinal submucosa (PSIS), 
and synthetic materials such as bioactive glass has been described [6-9]  
 Porcine small intestinal submucosa (“SurgiSIS”, Cook Biotech Inc, West 
Lafayette, IN) is a biologic, acellular, freeze-dried, soft tissue graft.  It is purified, washed 
in solutions to eradicate viruses, and sterilized.  Small intestinal submucosa mimics the 
extracellular matrix (ECM) environment.  Fibrillar collagens and adhesive glycoproteins 
serve as a scaffold for cellular migration, and regulatory factors such as 
glycosaminoglycans, proteoglycans, and growth factors are reportedly retained following 
processing [10].  Following implantation, SIS encourages angiogenesis, epithelial and 
connective tissue growth and differentiation, and evolution of recipient site ECM.  
Porcine SIS has been used in a wide variety of surgical applications including hernia 
repair, urethral and ureteral reconstruction, pelvic floor reconstruction, and chronic 
wound dressing.   
 The senior author (EP) previously reported a case series of 10 patients with nasal 
septal perforations repaired using an external rhinoplasty approach, bilateral bipedicled 
mucoperichondrial advancement flaps and interpositional graft consisting of porcine 
small intestinal submucosa [7].  A rate of closure of 100% was achieved in the early 
follow-up period.  This article updates the series to include 46 patients repaired using this 
approach, and reviews the series demographics, etiology, outcomes, and risk factors for 
perforation and complications of repair. 
 
Patients and Methods 
Following approval from the Institutional Review Board at Thomas Jefferson 
University, a retrospective chart review was performed on all patients undergoing nasal 
septal perforations repair using porcine small intestinal submucosa as an interpositional 
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graft by the senior author (EP), during the time period from 1998-2006. Of a total of 53 
patients undergoing septal perforation repair during this same time period, 46 patients 
underwent 47 repairs using PSIS interpositional graft and the surgical method. The 
remaining seven patients were closed using silicone sheeting, rib graft, or local 
advancement flaps alone because of large unstable defects or inadequate mucosa.  Two 
patients in the series had tissue expanders placed, with the expanded mucosa employed at 
the time of septal perforation repair. One patient underwent revision septal perforation 
repair with repeated PSIS placement. 
Patients with symptomatic nasal septal perforations were considered candidates 
for repair with PSIS graft.  Patients with a history of cocaine abuse were required to 
abstain for at least 6 months prior to consideration of repair, as well as demonstrate a 
negative preoperative drug screen. Laboratory workup included screening for 
granulomatous diseases, rheumatologic diseases and syphilis.   
Patients received perioperative antibiotics and corticosteroids.  Nasal septal 
perforation closure was achieved using either an endonasal (n=6) or open rhinoplasty 
(n=41) approach with bilateral mucoperichondrial advancement flaps covering an 
interpositional PSIS graft  [7]. The PSIS was rehydrated in a gentamicin-normal saline 
solution for 10 minutes, then shaped and trimmed to the appropriately sized 
interpositional graft [7]. Septal biopsies were performed intraoperatively.  Patients had 
0.25 mm silicone splints secured on either side of the repair, which were removed after 3 
weeks.   
A retrospective chart review abstracted presenting symptoms and an attempt was 
made to determine the general effect of surgical repair on these symptoms. Two authors 
(PSM and AAS) subjectively determined the severity of these symptoms both pre and 
post-operatively as described by office notes and symptom questionnaires.  A 4-point 
scale was created, with “0” representing a lack of symptoms (e.g. for epistaxis, “0” means 
patient did not experience epistaxis), and scores of 1, 2, and 3 representing mild, 
moderate, and severe symptoms, respectively.  
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Results: 
 
Twenty-four percent (11/46) of patients were male.  Patient ages ranged from 17-
69 years with a mean of 40.4 (stddev=11.4). 63% (29/46) were self-described lifetime 
nonsmokers, while 19.6% (9/46) were former smokers and 17.4% (8/46) current smokers.  
The size of perforations ranged from 0.5 cm to 4.7 cm in largest dimension, with a mean 
approximately 1.7 cm (stddev=0.8 cm).  Patients were followed for an average of 18.3 
months (stddev=14.2 months), with a range in follow up from 6 months to 4.9 years.  See 
Table 1 for a summary of patient characteristics.   
 
Table 1.  Patient Characteristics 
Age (mean, std) 40.4 11.4 
Gender (N=46)    
    Male  11 23.9% 
    Female  35 78.3% 
Smoking Status (N=46)    
Non-Smoker 29 63.0% 
Former Smoker 9 19.6% 
Current Smoker 8 17.4% 
Perforation Sizes (N=47)    
    <10 mm 5 10.6% 
    10-19 mm 29 61.7% 
    20-29 mm 7 14.9% 
    30-39 mm 4 8.5% 
    >=40 mm 1 2.1% 
Largest Dimension of Perforation (mean, std)* 1.7 cm 0.8 cm 
Follow Up (mean, std) 18.3 mos 14.2 mos 
N=46 patients, or 47 procedures   
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Previous surgery, cocaine use, and previous trauma were the most common 
determined etiologies for these patients (Table 2).  
 
Table 2.  Contributing Etiology N=47 % 
Surgery 20 42.6% 
Cocaine Use  13 27.7% 
Trauma (i.e. fracture, picking, 
cautery) 11 23.4% 
Idiopathic 5 10.6% 
Infection/Septal Abscess 4 8.5% 
Granulomatous/Systemic 3 6.4% 
Sprays 2 4.3% 
Occupational Exposure 1 2.1% 
Some patients had more than one contributing etiology  
 
The three most frequently reported presenting symptoms were, in descending 
order:  nasal obstruction, crusting, and epistaxis (Table 3).  
  
Table 3.  Presenting Symptoms     N=47 % 
Obstruction 38 80.9% 
Crusting 27 57.4% 
Epistaxis 21 44.7% 
Chronic Sinusitis/Chronic Sinus 
Complaints 19 40.4% 
PND 13 27.7% 
Anosmia 6 12.8% 
Whistling 3 6.4% 
Rhinorrhea 3 6.4% 
Some patients had more than one presenting symptom 
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Outcomes 
 
Closure 
Forty-seven PSIS repairs were performed on 46 patients.  Of the total 47 
procedures, 41 (87.2%) continued to be closed at the site of repair during the follow up 
period.  Two procedures were staged, with a planned incompletely closed perforation at 
the first stage.  Excluding these staged procedures, 41/45 (91.1%) continued to be closed 
at the site of repair during the follow up period.   
 
Failure 
Of the total 47 procedures, six perforations (12.8%) remained during the follow 
up period.  Two of the perforations were in the patients scheduled to undergo staged 
procedures and will be discussed below.  The remaining four perforations developed in 
patients who underwent primary procedures.  
Of the total 45 planned complete closures, one patient developed a perforation at 
the site of closure after the immediate post-operative period (termed “Reperforation”).  
Three patients developed perforations at sites separate from the site of surgical repair 
(termed “Second Perforation”).  Of note, one of these appeared to be at the site of a splint 
suture and remains stable at 2mm. 
As mentioned above, two failures were in patients scheduled to undergo staged 
procedures with the expectation of incomplete closure in the immediate post-operative 
period (termed “Residual Perforation”).  Only one of these patients had undergone 
secondary procedure at the time of writing.  The other staged patient had her perforation 
significantly reduced (1.5 cm to 0.2cm) by the initial procedure, and has not pursued the 
second stage of operation given the relief of presenting symptoms. 
The outcomes of the procedures are listed in Table 4.   
 
 
Table 4.  Outcomes N % Description 
Primary Procedures 45  Planned complete closure 
Staged Procedures 2   Planned incomplete closure 
Total  47   Total # PROCEDURES (not patients) 
    
    Closures 41 87.2% Total # of HEALED perforations at site of repair, including staged 
    
    Failures 6 12.8%  Total # of perforations during the follow up period, including staged 
  Reperforation 1 2.1% Perforation at repair site, initially closed 
  Second Perforation 3 6.4% Perforation separate from repair site 
      Residual Perforation 2 4.3% Intentional perforation in the  immediate post-operative period 
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As the ultimate goal of this analysis to is to identify risk factors that might allow proper 
selection of patients and individualized procedures, it is instructive to examine carefully 
the failures, which include patients who required staged procedures, developed 
reperforation, or second perforations 
 Table 5 describes the patients in this study who had subtotal closure of their nasal 
septum.  Two procedures were planned staged procedures.  Both of these patients had 
septal perforation repair attempts prior to initial consultation, and 3 cm perforations.     
One patient developed reperforation.  Patient 3 had a near-total perforation, 
approximately 4.7 cm x 3.4 cm with saddle nose deformity.  She had concurrent 
rhinoplasty and repair of nasal vestibular stenosis. Unfortunately, she restarted intranasal 
cocaine use postoperatively.  No closure was planned given the cocaine use and 
asymptomatic nature of this reperforated septum. 
 Two patients, Patients 4 and 5, had residual perforations.  Patient 4 represents the 
second stage of Patient 1.  She underwent placement of tissue expanders in the nasal 
floor.  Patient 5 is a patient with sarcoidosis, who required tissue expanders as well for 
adequate mucosal tissue for advancement.  She achieved approximately 80% closure and 
did not proceed with a subsequent procedure given the relief of her symptoms.  Of note, 
both procedures with tissue expander placement resulted in residual perforation.  The 
senior author has discontinued use of tissue expanders in the setting of nasal septal 
perforation repair.   
 Three patients (Patients 6, 7, and 8) developed new perforations at a site separate 
from the original perforation.  The second perforations arose at sites near the original 
perforation and may represent areas of denuded septum during the advancement flap 
rotation or devascularized tissue from elevation and rotation of the mucoperichondrial 
flaps.  One of these clearly resulted from the splint suture in the anterior septum. 
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Table 5.  Description of Patients with Incomplete Closure       
ID Age Sex Etiology Perforation Size (mm) Repair Outcome 
Defect 
Size 
(mm) 
Notes 
        
Largest 
Dimension 
Other 
Dimension 
        
1* 53 F 
infection - 
MRSA 30 13 Open/Surgisis/MP flap/Buccal flap Staged 22 prior perforation repair 
2 39 F cocaine/surgery 30 15 Surgisis/MP flap Staged 10 h/o prior perf repair, refused rhinoplasty, no floor mucosa 
3 32 F cocaine 47 34 Surgisis/MP flap Reperforation 5 near total perf;cont'd cocaine; revision rhinoplasty 
4* 57 F 
infection - 
MRSA 22 NR Surgisis/MP flap/T XP Residual 3 had previous perforation repair x2, 2nd stage 
5 44 F sarcoid/surgery 32 22 Surgisis/MP flap/T XP Residual 6 sarcoidosis 
6 17 F idiopathic 15 10 Surgisis/MP flap 
2nd 
perforation 3 superior to repair, rheum w/u ongoing 
7 35 M surgery 20 18 Surgisis/MP flap 
2nd 
perforation 2 posterior to repair 
8 41 F surgery 15 NR Surgisis/MP flap 
2nd 
perforation 2 anterior to repair, from splint suture 
 * - denotes that this is the same patient, who underwent 2 separate procedures   
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Symptoms 
The results of the preoperative and postoperative profile for the three most 
commonly reported presenting symptoms are documented in Table 6. Each of the 3 
symptoms is measured on a 4-point scale (0, 1, 2, 3) based on severity of the symptom.  
A clear shift toward improvement is seen postoperatively.  We considered the difference 
in score (change score = post-op score – pre-op score) as a measure of the change in 
severity of the symptom. The number of pre-repair symptoms and post-repair symptoms 
differ, because one patient underwent two procedures.  The patient who did not complete 
the 2 stage procedure is excluded from this table.  
Table 6.  Symptom Scores     
  Pre-Repair Symptoms  Post-Repair Symptoms  
Crusting N % N % 
0 (Not a symptom) 17 37.8 38 82.6 
1 (Mild) 12 26.7 7 15.2 
2 (Moderate) 13 28.9 1 2.2 
3 (Severe) 3 6.7 0 0 
Epistaxis         
0 (Not a symptom) 24 53.3 41 89.1 
1 (Mild) 13 28.9 5 10.9 
2 (Moderate) 7 15.6 0 0 
3 (Severe) 1 2.2 0 0 
Obstruction         
0 (Not a symptom) 7 15.9 21 45.7 
1 (Mild) 16 36.4 17 37 
2 (Moderate) 18 40.9 6 13 
3 (Severe) 3 6.8 2 4.4 
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We found that major symptoms improved after surgery (Table 7), as expected. 
Even the patients with subtotal closure of the nasal septal perforation routinely 
experienced a dramatic improvement of their symptoms, sometimes obviating the 
indications for further surgical repair. Table 7 displays the frequencies of each possible 
change score (-3 to +2, with negative values indicating improvement in severity of 
symptoms) and tests whether, on average, the change score is different from 0. We used 
the Wilcoxon signed rank test for this, since the data, being a difference of scores, is quite 
non-normal. We found that all the symptoms showed improvement on average after 
surgery. 47% showed improvement in epistaxis, 54.55% in obstruction and 55.56% in 
crusting. 
We did note a persistent and paradoxical increase in obstructive symptoms in 5 
patients (10.9%) postoperatively.  Two of these patients were found to have exuberant 
granulation and regrowth at the repair site that necessitated surgical intervention.  The 
remainder experienced primarily chronic sinus complaints. 
 
 
Table 7. Change in Symptom Scores               
Change from Pre-
Repair to Post-Repair 
Epistaxis* Obstruction** Crusting* 
n 
Cumulative 
% p  n 
Cumulative 
% p  n 
Cumulative 
% p  
-3 1 2.27 <.0001 1 2.27 0.0002 2 4.44 <.0001 
-2 4 11.36   9 22.73   13 33.33   
-1 16 47.73   14 54.55   10 55.56   
0 22 97.73   14 86.36   17 93.33   
+1 1 100   5 97.73   2 97.78   
+2 0 100   1 100   1 100   
*n=45, **n=44          
p from Wilcoxon signed rank test         
 
 
Taking into account all patients, including planned staged patients, statistical 
analysis does correlate repair outcome with perforation size.  Table 8 compares, using a 
two-sample t-test, the mean perforation size between patients with closed perforation 
post-surgery (~1.5 cm) and patients with the perforation not closed post-surgery (2.6 cm). 
We find that this average difference of 1.1 cm is statistically significant (p-value=0.011), 
reinforcing the observation that larger perforations are more likely to have worse 
outcomes.   
 
Table 8. Perforation 
Size and Repair 
Outcome 
Largest OR Measurement* 
mean std 
Perforation NOT Closed 26.22 10.02 
Perforation Closed 15.21 5.63 
Mean Difference 11.01 p = 0.011 
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*n=45   
 
Other results 
Biopsy results were available for 35 patients.  Two of these (5.7%) supported a 
diagnosis for granulomatous disease, and the remainder demonstrated various degrees of 
inflammation without contributing significantly to the diagnostic evaluation.  One of the 
biopsy positive patients was known to have sarcoidosis, and the other had no clinical 
evidence supporting a systemic disease process.  Of two patients known to have 
sarcoidosis, one (50%) revealed granulomatous disease on biopsy.  No nasal septal 
biopsies led to diagnosis of an unknown systemic process.  This is consistent with the 
findings of Diamantopoulos et al. [11] that demonstrate the low yield of this convention. 
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Discussion 
 The septal perforation closure rates cited in this study correspond favorably with 
those reported by other authors. Reviews of the literature reveal that reconstruction of the 
nasal septum in three distinct layers using mucoperichondrial flaps with interpositional 
grafting achieves high rates of closure.  However, no consensus on the material for 
interpositional grafting is apparent.  Autologous grafts (temporalis fascia, septal cartilage 
and bone, pericranium, mastoid bone and perichondrium, tragal cartilage and 
perichondrium, ethmoid bone, iliac crest, conchal cartilage and skin graft) all require a 
donor site that can add to procedural morbidity, complications such as hematoma and 
wound infection, and increased operative time.  Autografts can result in thin, awkward 
flaps (fascia), or bulky material that must be modified or thinned (bony and cartilaginous 
grafts).  Allografts and xenografts that can reconstruct the cartilaginous layer with similar 
outcomes may offer a compelling alternative if their use is not associated with increased 
risk. Currently, published available alternatives include acellular human dermal [6, 8], 
bioglass [9], and porcine small intestinal submucosa [7].  All of these obviate the need for 
graft harvest, and eliminate donor site morbidity.  
 The senior author (EP) previously published a series of 10 patients with nasal 
septal perforations repaired using an external rhinoplasty approach, mucoperichondrial 
bipedicled advancement flaps with interpositional graft using PSIS xenograft.  The results 
in this small case series with short follow up (3-12 months) were very promising, given 
the 100% closure rate. The present study includes longer follow-up data and a much 
larger number of patients.  The overall closure rate of 87.2% is comparable to rates cited 
by authors employing a wide variety of surgical approaches, techniques, and 
interpositional grafts [1].  
 PSIS was chosen as a material for interpositional grafting given the multiple 
advantages over autografts previously listed as well as theorized physiologic factors.  
Advantages over autografts are listed above.  Technical advantages of this graft include 
the ease with which the graft may be trimmed, shaped and modified, the uniformity of 
thickness, the ease of readiness (10 minute rehydration), and graft pliability.  The 
physiologic basis for use includes the preservation of extracellular matrix components 
that enhance wound healing.  The fibrillar collagens and glycoproteins provide a scaffold 
for epithelial and connective tissue migration.  Glycosaminoglycans, proteoglycans, and 
growth factors are retained and help to regulate the response to injury.  Thus, PSIS serves 
requisite functions as a bioactive interpositional graft similar to autografts.   
 PSIS is contraindicated in patients with allergy or sensitivity to porcine products.  
The porcine derivation of this product should certainly be disclosed to patients with 
potential religious or cultural objections to its use. 
 In our experience, PSIS successfully formed a neoseptum with sufficient integrity 
to remain stable during inspiratory and expiratory forces.  In the one patient who 
underwent second stage septal perforation repair, this neoseptum could be separated into 
two flaps that could receive a second interpositional graft of PSIS between the leafs.  In 
fact, the method of reconstructing the nasal septum in three layers with a bioactive 
interpositional graft could theoretically encourage neocartilage formation.  Two patients 
returned to the operating room in this series for management of nasal obstruction 
secondary to robust neoseptum formation.  Upon pathologic evaluation of specimen 
retrieved from the site of prior septal perforation repair with PSIS, one of the specimens 
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identified “fragments of fibrocartilage consistent with nasal septum”, while the other 
revealed “reactive fibrosis, scattered chronic inflammatory cells and focal multinucleated 
giant cell reaction.”   
 
Conclusions 
Surgical repair of nasal septal perforations using porcine small intestinal 
submucosa for interpositional grafting appears to be a viable alternative technique, with 
closure outcomes rivaling those generally accepted by otolaryngologists.  The 
comparable biologic activity, coupled with ease of use and lack of donor site morbidity 
present a clear advantage over autograft materials. 
 
 
Acknowledgment: The authors acknowledge Dr. Abhijit Dasgupta and the Division of 
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